{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:42:05Z","timestamp":1781721725031,"version":"3.54.5"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["5R01DK120108 , 1R01DK124580"],"award-info":[{"award-number":["5R01DK120108 , 1R01DK124580"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Urol."],"abstract":"<jats:p>Interstitial cystitis\/bladder pain syndrome is a chronic inflammatory pelvic pain syndrome of unknown etiology characterized by a number of lower urinary tract symptoms, including increased urinary urgency and frequency, bladder discomfort, decreased bladder capacity, and pelvic pain. While its etiology remains unknown, a large body of evidence suggests a role for changes in neurotrophin signaling, particularly that of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). Here, we evaluated the effects of pharmacological inhibition of the NGF receptor TrkA, BDNF receptor TrkB, and pan-neurotrophin receptor p75<jats:sup>NTR<\/jats:sup> on bladder function in acute (4-hour) and chronic (8-day) mouse models of cyclophosphamide (CYP)-induced cystitis. TrkA inhibition <jats:italic>via<\/jats:italic> ARRY-954 significantly increased intermicturition interval and bladder capacity in control and acute and chronic CYP-treatment conditions. TrkB inhibition <jats:italic>via<\/jats:italic> ANA-12 significantly increased intermicturition interval and bladder capacity in acute, but not chronic, CYP-treatment conditions. Interestingly, intermicturition interval and bladder capacity significantly increased following p75<jats:sup>NTR<\/jats:sup> inhibition <jats:italic>via<\/jats:italic> LM11A-31 in the acute CYP-treatment condition, but decreased in the chronic condition, potentially due to compensatory changes in neurotrophin signaling or increased urothelial barrier dysfunction in the chronic condition. Our findings demonstrate that these receptors represent additional potent therapeutic targets in mice with cystitis and may be useful in the treatment of interstitial cystitis and other inflammatory disorders of the bladder.<\/jats:p>","DOI":"10.3389\/fruro.2022.1037511","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T04:32:48Z","timestamp":1667881968000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of pharmacological neurotrophin receptor inhibition on bladder function in female mice with cyclophosphamide-induced cystitis"],"prefix":"10.3389","volume":"2","author":[{"given":"Harrison W.","family":"Hsiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice M.","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexi","family":"Ratkovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Vizzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1756287211398255","article-title":"Role of inflammation in bladder function and interstitial cystitis","volume":"3","author":"Grover","year":"2011","journal-title":"Ther Adv Urol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/iju.12308","article-title":"Bladder afferent hyperexcitability in bladder pain syndrome\/interstitial cystitis","volume":"21","author":"Yoshimura","year":"2014","journal-title":"Int J Urol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00192-010-1252-8","article-title":"Treatment choice, duration, and cost in patients with interstitial cystitis and painful bladder syndrome","volume":"22","author":"Anger","year":"2011","journal-title":"Int Urogynecol J"},{"key":"B4","article-title":"Crosstalk between the immune system and neural pathways in interstitial Cystitis\/Bladder pain syndrome","volume":"25","author":"Duh","year":"2018","journal-title":"Discovery Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2174\/157015911798376253","article-title":"Neurotrophins in the lower urinary tract: Becoming of age","volume":"9","author":"Frias","year":"2011","journal-title":"Curr Neuropharmacol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/nau.21022","article-title":"Nerve growth factor in bladder dysfunction: Contributing factor, biomarker, and therapeutic target: NGF in bladder dysfunction","volume":"30","author":"Ochodnick\u00fd","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2012.178","article-title":"Neurotrophins as regulators of urinary bladder function","volume":"9","author":"Ochodnick\u00fd","year":"2012","journal-title":"Nat Rev Urol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.08.187","article-title":"Urinary neurotrophic factors in healthy individuals and patients with overactive bladder","volume":"189","author":"Antunes-Lopes","year":"2013","journal-title":"J Urol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/330658a0","article-title":"Interleukin-l regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve","volume":"330","author":"Lindholm","year":"1987","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701148","article-title":"Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumor necrosis factor \u03b1","volume":"121","author":"Woolf","year":"1997","journal-title":"Br J Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.1997.00097.x","article-title":"Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis","volume":"79","author":"Lowe","year":"1997","journal-title":"Br J Urol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199805110-00038","article-title":"Rapid increase of NGF, BDNF and NT-3 mRNAs in inflamed bladder","volume":"9","author":"Oddiah","year":"1998","journal-title":"Neuroreport"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)61915-3","article-title":"Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients","volume":"161","author":"Okragly Angela","year":"1999","journal-title":"J Urol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1999.7254","article-title":"Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction","volume":"161","author":"Vizzard","year":"2000","journal-title":"Exp Neurol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-013-0033-5","article-title":"Increased TRPV4 expression in urinary bladder and lumbosacral dorsal root ganglia in mice with chronic overexpression of NGF in urothelium","volume":"51","author":"Girard","year":"2013","journal-title":"J Mol Neurosci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00515.2010","article-title":"Neurotrophin\/receptor expression in urinary bladder of mice with overexpression of NGF in urothelium","volume":"300","author":"Girard","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0304-3959(96)02993-4","article-title":"Sensitization of visceral afferents by nerve growth factor in the adult rat","volume":"66","author":"Dmitrieva","year":"1996","journal-title":"Pain"},{"key":"B18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-6793-7-9","article-title":"Exogenous overexpression of nerve growth factor in the urinary bladder produces bladder overactivity and altered micturition circuitry in the lumbosacral spinal cord","volume":"7","author":"Zvara","year":"2007","journal-title":"BMC Physiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2010.01.015","article-title":"Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis","volume":"166","author":"Pinto","year":"2010","journal-title":"Neuroscience"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.02.1502","article-title":"1677 intra-trigonal injection of botulinum toxin a in patients with refractory bladder pain syndrome decreases urinary neurotrophins and improves lower urinary tract symptoms","volume":"183","author":"Almeida","year":"2010","journal-title":"J Urol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/cne.10447","article-title":"Cystitis-induced upregulation of tyrosine kinase (TrkA, TrkB) receptor expression and phosphorylation in rat micturition pathways","volume":"454","author":"Qiao","year":"2002","journal-title":"J Comp Neurol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0173(02)00206-0","article-title":"BDNF: a neuromodulator in nociceptive pathways","volume":"40","author":"Pezet","year":"2002","journal-title":"Brain Res Brain Res Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-21-08476.1997","article-title":"Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord","volume":"17","author":"Michael","year":"1997","journal-title":"J Neurosci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nm0895-774","article-title":"The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule","volume":"1","author":"Mcmahon","year":"1995","journal-title":"Nat Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97837","article-title":"Role of proNGF\/p75 signaling in bladder dysfunction after spinal cord injury","volume":"128","author":"Ryu","year":"2018","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.12.088","article-title":"Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis","volume":"185","author":"Evans","year":"2011","journal-title":"J Urol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0208-6","article-title":"Targeting nerve growth factor (NGF) for pain management: What does the future hold for NGF antagonists","volume":"74","author":"Bannwarth","year":"2014","journal-title":"Drugs"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2006.1894","article-title":"Neurotrophin-regulated signalling pathways","volume":"361","author":"Reichardt","year":"2006","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-536-7_1","article-title":"The neurotrophin family of neurotrophic factors: An overview","volume-title":"Neurotrophic factors: Methods and protocols","author":"Skaper","year":"2012"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.12688\/f1000research.8434.1","article-title":"Recent advances in understanding neurotrophin signaling","volume":"5","author":"Bothwell","year":"2016","journal-title":"F1000Research"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/0959-4388(95)80062-X","article-title":"Early events in neurotrophin signalling via trk and p75 receptors","volume":"5","author":"Greene","year":"1995","journal-title":"Curr Opin Neurobiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuron.2006.12.018","article-title":"High affinity not in the vicinity","volume":"53","author":"Barker","year":"2007","journal-title":"Neuron"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00042.2013","article-title":"Expression and function of transforming growth factor-\u03b2 isoforms and cognate receptors in the rat urinary bladder following cyclophosphamide-induced cystitis","volume":"305","author":"Gonzalez","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00734.2005","article-title":"Role for pituitary adenylate cyclase activating polypeptide in cystitis-induced plasticity of micturition reflexes","volume":"290","author":"Braas","year":"2006","journal-title":"Am J Physiol.-Regul Integr Comp Physiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00367.2009","article-title":"Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function","volume":"298","author":"Schnegelsberg","year":"2010","journal-title":"Am J Physiol.-Regul Integr Comp Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1378\/chest.112.6_Supplement.321S","article-title":"Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock","volume":"112","author":"Dinarello","year":"1997","journal-title":"Chest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000143549.29867.4e","article-title":"Cyclophosphamide induced cystitis alters neurotrophin and receptor tyrosine kinase expression in pelvic ganglia and bladder","volume":"172","author":"Murray","year":"2004","journal-title":"J Urol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600893","article-title":"NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels","volume":"24","author":"Zhang","year":"2005","journal-title":"EMBO J"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1159\/000355175","article-title":"Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial Cystitis\/Bladder pain syndrome","volume":"92","author":"Liu","year":"2014","journal-title":"Urol Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11187.x","article-title":"Transient receptor potential vanilloid 1 mediates nerve growth factor-induced bladder hyperactivity and noxious input","volume":"110","author":"Frias","year":"2012","journal-title":"BJU Int"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00728.2007","article-title":"Blockade of NGF and trk receptors inhibits increased peripheral mechanical sensitivity accompanying cystitis in rats","volume":"295","author":"Guerios","year":"2008","journal-title":"Am J Physiol.-Regul Integr Comp Physiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/83.3.442","article-title":"Inflammation of the rat urinary bladder is associated with a referred thermal hyperalgesia which is nerve growth factor dependent","volume":"83","author":"Jaggar","year":"1999","journal-title":"Br J Anaesth"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2013.09.046","article-title":"The p75NTR signaling cascade mediates mechanical hyperalgesia induced by nerve growth factor injected into the rat hind paw","volume":"254","author":"Khodorova","year":"2013","journal-title":"Neuroscience"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2005.04173.x","article-title":"Primary afferent nociceptor mechanisms mediating NGF-induced mechanical hyperalgesia","volume":"21","author":"Malik-Hall","year":"2005","journal-title":"Eur J Neurosci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0304-3940(98)00713-7","article-title":"Nerve growth factor evokes hyperalgesia in mice lacking the low-affinity neurotrophin receptor p75","volume":"255","author":"Bergmann","year":"1998","journal-title":"Neurosci Lett"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2016.10.064","article-title":"The TRKA receptor mediates experimental thermal hyperalgesia produced by nerve growth factor: modulation by the p75 neurotrophin receptor","volume":"340","author":"Khodorova","year":"2017","journal-title":"Neuroscience"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-072116-031121","article-title":"Nerve growth factor and pain mechanisms","volume":"40","author":"Denk","year":"2017","journal-title":"Annu Rev Neurosci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/science.8079174","article-title":"Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor","volume":"265","author":"Dobrowsky","year":"1994","journal-title":"Science New Ser"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.90501.2008","article-title":"Role of p75 NTR in female rat urinary bladder with cyclophosphamide-induced cystitis","volume":"295","author":"Klinger","year":"2008","journal-title":"Am J Physiol.-Ren Physiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e00260","DOI":"10.1002\/phy2.260","article-title":"The mouse cyclophosphamide model of bladder pain syndrome: tissue characterization, immune profiling, and relationship to metabotropic glutamate receptors","volume":"2","author":"Golubeva","year":"2014","journal-title":"Physiol Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64244-9","article-title":"Differential expression of bladder neurotrophic factor mRNA in male and female rats after bladder outflow obstruction","volume":"168","author":"Zvara","year":"2002","journal-title":"J Urol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-005-0114-z","article-title":"Changes in galanin immunoreactivity in rat micturition reflex pathways after cyclophosphamide-induced cystitis","volume":"324","author":"Zvarova","year":"2006","journal-title":"Cell Tissue Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00386.2017","article-title":"BDNF overexpression in the bladder induces neuronal changes to mediate bladder overactivity","volume":"315","author":"Kashyap","year":"2018","journal-title":"Am J Physiol.-Ren Physiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.pneurobio.2005.11.002","article-title":"Fos, nociception and the dorsal horn","volume":"77","author":"Coggeshall","year":"2005","journal-title":"Prog Neurobiol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2174\/1876386300902010011","article-title":"C-fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury","volume":"2","author":"Gao","year":"2009","journal-title":"Open Pain J"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2009.07.044","article-title":"Phosphorylation of extracellular signal-regulated kinases (pERK1\/2) in bladder afferent pathways with cyclophosphamide (CYP)-induced cystitis","volume":"163","author":"Corrow","year":"2009","journal-title":"Neuroscience"},{"key":"B57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12974-020-1704-0","article-title":"BDNF promotes activation of astrocytes and microglia contributing to neuroinflammation and mechanical allodynia in cyclophosphamide-induced cystitis","volume":"17","author":"Ding","year":"2020","journal-title":"J Neuroinflamm"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-12-04469.2001","article-title":"Brain-derived neurotrophic factor is released in the dorsal horn by distinctive patterns of afferent fiber stimulation","volume":"21","author":"Lever","year":"2001","journal-title":"J Neurosci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2008.152439","article-title":"Brain-derived neurotrophic factor enhances the excitability of rat sensory neurons through activation of the p75 neurotrophin receptor and the sphingomyelin pathway","volume":"586","author":"Zhang","year":"2008","journal-title":"J Physiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2014.994506","article-title":"Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target","volume":"19","author":"Nijs","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"B61","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neuroscience.2012.12.044","article-title":"Brain-derived neurotrophic factor, acting at the spinal cord level, participates in bladder hyperactivity and referred pain during chronic bladder inflammation","volume":"234","author":"Frias","year":"2013","journal-title":"Neuroscience"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.29.051605.112929","article-title":"NEUROTROPHINS: Mediators and modulators of pain","volume":"29","author":"Pezet","year":"2006","journal-title":"Annu Rev Neurosci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e81547","DOI":"10.1371\/journal.pone.0081547","article-title":"In vivo regulation of brain-derived neurotrophic factor in dorsal root ganglia is mediated by nerve growth factor-triggered akt activation during cystitis","volume":"8","author":"Qiao","year":"2013","journal-title":"PloS One"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2015.06.008","article-title":"The effects of generally administered anti\u2013nerve growth factor receptor (p75NTR) antibody on pain-related behavior, dorsal root ganglia, and spinal glia activation in a rat model of brachial plexus avulsion","volume":"40","author":"Kobayashi","year":"2015","journal-title":"J Handb Surg"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/BF01991127","article-title":"Cyclophosphamide-induced cystitis in rats: involvement of capsaicin-sensitive primary afferents","volume":"38","author":"Maggi","year":"1993","journal-title":"Agents Actions"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01305","article-title":"Characterization and validation of a chronic model of cyclophosphamide-induced interstitial Cystitis\/Bladder pain syndrome in rats","volume":"11","author":"Aug\u00e9","year":"2020","journal-title":"Front Pharmacol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.5213\/inj.1835062.531","article-title":"Animal modelling of interstitial Cystitis\/Bladder pain syndrome","volume":"22","author":"Birder","year":"2018","journal-title":"Int Neurourol J"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/nau.21180","article-title":"Functional characterization of a chronic cyclophosphamide-induced overactive bladder model in mice","volume":"30","author":"Boudes","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"B69","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/iju.14229","article-title":"Interstitial cystitis\/bladder pain syndrome: The evolving landscape, animal models and future perspectives","volume":"27","author":"Akiyama","year":"2020","journal-title":"Int J Urol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.01.124","article-title":"Interstitial cystitis and painful bladder syndrome","volume":"177","author":"Payne","year":"2007","journal-title":"J Urol"},{"key":"B71","article-title":"Epidemiology of interstitial cystitis","volume":"64","author":"Oravisto","year":"1975","journal-title":"Ann Chir. Gynaecol Fenn"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2223-4683.2015.10.01","article-title":"The enigma of men with interstitial cystitis\/bladder pain syndrome","volume":"4","author":"Arora","year":"2015","journal-title":"Transl Androl Urol"}],"container-title":["Frontiers in Urology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fruro.2022.1037511\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T04:32:54Z","timestamp":1667881974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fruro.2022.1037511\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":72,"alternative-id":["10.3389\/fruro.2022.1037511"],"URL":"https:\/\/doi.org\/10.3389\/fruro.2022.1037511","relation":{},"ISSN":["2673-9828"],"issn-type":[{"value":"2673-9828","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"article-number":"1037511"}}